AKESIS PHARMACEUTICALS, INC.
AKESIS PHARMACEUTICALS, INC. (AKES.OB) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 105 transactions totaling $7.5M, demonstrating a bullish sentiment with $7.5M in net insider flow. The most recent transaction on Sep 23, 2008 involved a purchase of 5,000 shares valued at $2.5K.
AKES.OB Insider Activity Summary
Who Is Buying AKES.OB Stock?
No significant insider buying has been recorded for AKES.OB in the recent period.
Who Is Selling AKES.OB Stock?
No significant insider selling has been recorded for AKES.OB in the recent period.
Is AKESIS PHARMACEUTICALS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AKES.OB is bullish with an Insider Alignment Score of 100/100 and a net flow of $7.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
AKES.OB Frequently Asked Questions
Understanding AKES.OB Insider Activity
Insider trading at AKESIS PHARMACEUTICALS, INC. (AKES.OB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading AKES.OB stock, having executed 105 transactions in the past 90 days. The most active insider is Kevin J. Kinsella (Executive), who has made 49 transactions totaling $5.3M.
Related Tools
Track AKESIS PHARMACEUTICALS, INC. Insider Activity
Get notified when executives and directors at AKES.OB file new Form 4 transactions